Log in
Log in
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     
Sign up
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     

CORMEDIX INC.

(CRMD)
  Report
Real-time Estimate Cboe BZX  -  01:20 2022-11-29 pm EST
4.225 USD   +2.05%
11/10Transcript : CorMedix Inc., Q3 2022 Earnings Call, Nov 10, 2022
CI
11/10CORMEDIX INC. Management's Discussion and Analysis of Financial Condition and Results of Operations. (form 10-Q)
AQ
11/10CorMedix Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022
CI
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisionsFunds 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector news
Days
:
Hours
:
Minutes
:
Seconds
Communiqués de presse de la société CORMEDIX INC.
11/10CORMEDIX INC. Management's Discussion and Analysis of Financial Condition and Results ..
AQ
11/10Cormedix : Q3 Earnings Snapshot
AQ
11/10CorMedix Inc. Reports Third Quarter 2022 Financial Results and Provides Business Update
AQ
11/07CorMedix Inc. Announces CMS Revision to NTAP Reimbursement of DefenCath
AQ
11/02CorMedix Inc. to Report Third Quarter 2022 Financial Results and Provide a Corporate Up..
AQ
10/21Cormedix Inc. : Changes in Registrant's Certifying Accountant, Financial Statements and Ex..
AQ
10/20CorMedix Inc. Announces Abstract Presentation at Upcoming American Society of Nephrolog..
AQ
10/17Cormedix Inc. : Submission of Matters to a Vote of Security Holders (form 8-K)
AQ
09/07CorMedix Inc. to Present at the H.C. Wainwright Annual Global Investment Conference
AQ
08/11CORMEDIX INC. Management's Discussion and Analysis of Financial Condition and Results ..
AQ
08/11Cormedix : Reports SECOND Quarter AND SIX MONTH 2022 Financial Results and Provides Busine..
PU
08/11Cormedix : Q2 Earnings Snapshot
AQ
08/11CorMedix Inc. Reports Second Quarter and Six Month 2022 Financial Results and Provides ..
AQ
08/09Cormedix : ANNOUNCES REGULATORY AND MANUFACTURING UPDATES - Form 8-K
PU
08/09Cormedix Inc. : Other Events, Financial Statements and Exhibits (form 8-K)
AQ
08/08CorMedix Inc. Announces Regulatory and Manufacturing Updates
AQ
08/01CorMedix Inc. To Report Second Quarter 2022 Financial Results and Provide a Corporate U..
AQ
06/1324/7 Market News : 5 Pharma Company Analyst Targets and most Bullish Argument for each
AQ
06/135 Pharma Company Analyst Targets and most Bullish Case for each
AQ
06/08CorMedix to Participate at the JMP Securities Life Sciences Conference
AQ
05/12CORMEDIX INC. Management's Discussion and Analysis of Financial Condition and Results ..
AQ
05/12Cormedix : Q1 Earnings Snapshot
AQ
05/12Cormedix Inc. : Results of Operations and Financial Condition, Other Events, Financial Sta..
AQ
05/12CorMedix Inc. Reports First Quarter 2022 Financial Results and Provides Business Update
AQ
05/12CorMedix Inc. Announces Leadership Updates and Operational Changes
AQ
05/03CorMedix Inc. to Report First Quarter 2022 Financial Results and Provide a Corporate Up..
AQ
04/07CorMedix Inc. Announces Scientific Advisory Board to Support Commercialization and Pipe..
AQ
04/04CorMedix Inc. to Present at the 21st Annual Needham Virtual Healthcare Conference
AQ
03/29Cormedix : REPORTS fourth QUARTER and full year 2021 FINANCIAL RESULTS AND PROVIDES BUSINE..
PU
03/29Cormedix : Q4 Earnings Snapshot
AQ
03/29CORMEDIX INC. Management's Discussion and Analysis of Financial Condition and Results ..
AQ
03/29CorMedix Inc. Reports Fourth Quarter and Full Year 2021 Financial Results and Provides ..
AQ
03/29Cormedix inc. - announces fda acceptance of resubmission of new drug application for de..
AQ
03/28Cormedix : ANNOUNCES FDA ACCEPTANCE of RESUBMISSION of NEW DRUG APPLICATION FOR DEFENCATH ..
PU
03/28Cormedix Inc. : Other Events, Financial Statements and Exhibits (form 8-K)
AQ
03/28CorMedix Inc. Announces FDA Acceptance of Resubmission of New Drug Application for Defe..
AQ
03/22CorMedix Inc. to Report Fourth Quarter and Fiscal Year 2021 Financial Results and Provi..
AQ
03/21Cormedix : ANNOUNCES THE APPOINTMENT OF CHIEF EXECUTIVE OFFICER - Form 8-K
PU
03/21Cormedix Inc. : Change in Directors or Principal Officers, Other Events, Financial Stateme..
AQ
03/17CorMedix Inc. Announces the Appointment of Chief Executive Officer
AQ
02/28Cormedix : ANNOUNCES RESUBMISSION of NEW DRUG APPLICATION FOR DEFENCATH - Form 8-K
PU
02/28Cormedix Inc. : Other Events, Financial Statements and Exhibits (form 8-K)
AQ
02/28Cormedix Inc. Announces Resubmission of New Drug Application for DefenCath
AQ
01/04CorMedix to Participate in Upcoming January Conferences
AQ
2021Cormedix Inc. : Change in Directors or Principal Officers, Financial Statements and Exhibi..
AQ
2021Cormedix Inc. : Submission of Matters to a Vote of Security Holders (form 8-K)
AQ
2021Cormedix inc. reports third quarter 2021 financial results and provides business update
AQ
2021Cormedix : Q3 Earnings Snapshot
AQ
2021CORMEDIX INC. REPORTS THIRD QUARTER 2021 FINANCIAL RESULTS AND PROVIDES BUSINESS UPDATE..
PU
2021CORMEDIX INC. Management's Discussion and Analysis of Financial Condition and Results ..
AQ
2021CorMedix Inc. Reports Third Quarter 2021 Financial Results and Provides Business Update
AQ
2021CorMedix Inc. to Report Third Quarter 2021 Financial Results and Provide a Corporate Up..
PU
2021CorMedix Inc. to Report Third Quarter 2021 Financial Results and Provide a Corporate Up..
AQ
2021Cormedix Inc. : Change in Directors or Principal Officers, Financial Statements and Exhibi..
AQ
2021Cormedix Inc. : Change in Directors or Principal Officers (form 8-K)
AQ
2021Cormedix Inc. : Announces Executive Leadership Changes
AQ
2021Cormedix : ANNOUNCES REGULATORY UPDATE (Form 8-K)
PU
2021Cormedix Inc. : Other Events, Financial Statements and Exhibits (form 8-K)
AQ
2021Cormedix Inc. : Announces Regulatory Update
AQ
2021Cormedix : Reports second quarter and six month 2021 financial results and provides busine..
PU
2021Cormedix : At Market Issuance Sales Agreement (Form 8-K)
PU
2021Cormedix Inc. : Other Events, Financial Statements and Exhibits (form 8-K)
AQ
2021Cormedix : Q2 Earnings Snapshot
AQ
2021Cormedix : REPORTS Second QUARTER and six month 2021 FINANCIAL RESULTS AND PROVIDES BUSINE..
PU
2021Cormedix : Management's Discussion and Analysis of Financial Condition and Results of Oper..
AQ
2021CorMedix Inc. Reports Second Quarter and Six Month 2021 Financial Results and Provides ..
GL
2021CorMedix Inc. to Report Second Quarter 2021 Financial Results and Provide a Corporate U..
GL
2021CorMedix Inc. Completes Sale of $1.3 Million of NOL Tax Benefits Through The New Jersey..
GL
2021CorMedix Inc. to Participate in Fireside Chat at the JMP Securities Life Sciences Confe..
GL
2021CorMedix Inc. to Present at the Jefferies Virtual Healthcare Conference
GL
2021Cormedix Inc. : Other Events, Financial Statements and Exhibits (form 8-K)
AQ
2021Cormedix : Q1 Earnings Snapshot
AQ
2021Cormedix : Management's Discussion and Analysis of Financial Condition and Results of Oper..
AQ
2021Cormedix Inc. : Reports First Quarter 2021 Financial Results and Provides Business Update
AQ
2021CorMedix Inc. Announces Appointment of Chief Commercial Officer
GL
1  2  3Next
Upcoming event on CORMEDIX INC.